New research published online in June in the journal "Nature Medicine" finds that the TNF inhibitor etanercept (Enbrel) may offer treatment and hope to people with autosomal dominant polycystic kidney disease (ADPKD). ADPKD is a genetically inherited renal disease that affects about 1 in 800 people. The disease causes the kidneys to develop cysts and since there are no treatments currently available to prevent the cysts, ADPKD can eventually lead to end stage renal f...
Read more »Should I use diapers for incontinence? Someone recently asked this question in the "Ask a Question"... Read more »
An article recently appeared in the July, 2007 issue of "The Journal of Pain." And I found it... Read more »
In one of my SharePosts from the American Academy of Pain Management's Clinical Meeting in... Read more »
In the U.S., in fact in most free societies, presumption of innocence is one of the key tenets of... Read more »
You need to help me a lot with this one. All of you who read my articles here are motivated to... Read more »
(Ivanhoe Newswire) -- When a patient is treated for kidney cancer, surgeons remove the affected kidney as part of treatment. However, new research... Read summary »
(Ivanhoe Newswire) -- A protein found in common garden peas could be the key to saving the lives of millions of people who suffer from high blood... Read summary »
(Ivanhoe Newswire) -- A common procedure could stop the cognitive impairment often seen in patients with chronic kidney disease. Researchers report... Read summary »
(Ivanhoe Newswire)-- A new study reveals three genes that contain common mutations may put some people at a higher risk for kidney disease. More than... Read summary »
(Ivanhoe Newswire) -- Type 1 diabetics in need of a kidney transplant may increase their long-term survival rate with a simultaneous pancreas-kidney... Read summary »